CervoMed, Inc. (CRVO)
2.44
+0.01
(+0.41%)
USD |
NASDAQ |
Sep 21, 16:00
2.44
0.00 (0.00%)
After-Hours: 20:00
CervoMed Shareholders Equity (Quarterly) : 22.96M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.96M |
| March 31, 2026 | 10.62M |
| December 31, 2025 | 18.22M |
| September 30, 2025 | 26.01M |
| June 30, 2025 | 33.44M |
| March 31, 2025 | 34.63M |
| December 31, 2024 | 39.20M |
| September 30, 2024 | 45.64M |
| June 30, 2024 | 49.98M |
| March 31, 2024 | 5.336M |
| December 31, 2023 | 7.377M |
| September 30, 2023 | 9.574M |
| June 30, 2023 | 14.23M |
| March 31, 2023 | 16.28M |
| December 31, 2022 | -33.29M |
| September 30, 2022 | 24.05M |
| June 30, 2022 | 26.67M |
| March 31, 2022 | 30.62M |
| December 31, 2021 | 34.91M |
| September 30, 2021 | 38.13M |
| June 30, 2021 | 50.17M |
| March 31, 2021 | 53.65M |
| December 31, 2020 | 24.81M |
| September 30, 2020 | 28.72M |
| June 30, 2020 | 32.88M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.90M |
| December 31, 2019 | 20.13M |
| September 30, 2019 | 13.52M |
| June 30, 2019 | 16.18M |
| March 31, 2019 | 12.96M |
| December 31, 2018 | 15.61M |
| September 30, 2018 | 20.91M |
| June 30, 2018 | 27.30M |
| March 31, 2018 | 29.72M |
| December 31, 2017 | 21.23M |
| September 30, 2017 | 6.357M |
| June 30, 2017 | 1.168M |
| March 31, 2017 | -19.12M |
| December 31, 2016 | 9.185M |
| September 30, 2016 | 11.49M |
| June 30, 2016 | 14.03M |
| March 31, 2016 | 16.58M |
| December 31, 2015 | 16.44M |
| September 30, 2015 | 19.07M |
| June 30, 2015 | 31.81M |
| March 31, 2015 | 35.25M |
| December 31, 2014 | 38.17M |
| September 30, 2014 | 42.80M |
| June 30, 2014 | 45.30M |
| March 31, 2014 | 12.21M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.99M |
| Total Liabilities (Quarterly) | 3.032M |
| Current Ratio | 8.466 |